These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 23591747

  • 1. Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.
    Gao M, Liu D.
    AAPS J; 2013 Jul; 15(3):744-52. PubMed ID: 23591747
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y, Duan Y, Yang X, Sun L, Liu M, Wang Q, Ma X, Zhang W, Li X, Hu W, Miao RQ, Xiang R, Hajjar DP, Han J.
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
    Jin SH, Yang JH, Shin BY, Seo K, Shin SM, Cho IJ, Ki SH.
    Toxicol Appl Pharmacol; 2013 Aug 15; 271(1):95-105. PubMed ID: 23651738
    [Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM, Gang GT, Kim DK, Kim YD, Koo SH, Lee CH, Choi HS.
    J Biol Chem; 2014 Jan 10; 289(2):1079-91. PubMed ID: 24265317
    [Abstract] [Full Text] [Related]

  • 5. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA, Kim HK, Bae KH, Seo HY, Kim HS, Jang BK, Jung GS, Lee IK, Kim MK, Park KG.
    Exp Mol Med; 2014 Jan 24; 46(1):e73. PubMed ID: 24458133
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase.
    Choi YJ, Suh HR, Yoon Y, Lee KJ, Kim DG, Kim S, Lee BH.
    Arch Pharm Res; 2014 Jan 24; 37(9):1169-76. PubMed ID: 24633463
    [Abstract] [Full Text] [Related]

  • 7. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade HJ, Kuipers F, Plösch T.
    Am J Physiol Endocrinol Metab; 2009 Nov 24; 297(5):E1171-8. PubMed ID: 19724022
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.
    Escolà-Gil JC, Julve J, Llaverias G, Urpi-Sarda M, Silvennoinen R, Lee-Rueckert M, Andres-Lacueva C, Blanco-Vaca F.
    Transl Res; 2013 Feb 24; 161(2):110-7. PubMed ID: 23146569
    [Abstract] [Full Text] [Related]

  • 9. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W, Zhang T, Cheng J, Zhou X, Qu X, Hu H.
    Pharmacology; 2010 Feb 24; 86(5-6):306-12. PubMed ID: 21071998
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
    Yap F, Craddock L, Yang J.
    Int J Biol Sci; 2011 Feb 24; 7(5):645-50. PubMed ID: 21647332
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
    Kim YW, Kim YM, Yang YM, Kim TH, Hwang SJ, Lee JR, Kim SC, Kim SG.
    Free Radic Biol Med; 2010 Feb 15; 48(4):567-78. PubMed ID: 20005944
    [Abstract] [Full Text] [Related]

  • 12. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
    Gao M, Bu L, Ma Y, Liu D.
    PLoS One; 2013 Feb 15; 8(6):e65641. PubMed ID: 23762402
    [Abstract] [Full Text] [Related]

  • 13. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
    Hwahng SH, Ki SH, Bae EJ, Kim HE, Kim SG.
    Hepatology; 2009 Jun 15; 49(6):1913-25. PubMed ID: 19378344
    [Abstract] [Full Text] [Related]

  • 14. A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation.
    Hijmans BS, Tiemann CA, Grefhorst A, Boesjes M, van Dijk TH, Tietge UJ, Kuipers F, van Riel NA, Groen AK, Oosterveer MH.
    FASEB J; 2015 Apr 15; 29(4):1153-64. PubMed ID: 25477282
    [Abstract] [Full Text] [Related]

  • 15. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
    Kay HY, Kim WD, Hwang SJ, Choi HS, Gilroy RK, Wan YJ, Kim SG.
    Antioxid Redox Signal; 2011 Oct 15; 15(8):2135-46. PubMed ID: 21504366
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of gomisin N against hepatic steatosis through AMPK activation.
    Yun YR, Kim JH, Kim JH, Jung MH.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):1095-1101. PubMed ID: 27914812
    [Abstract] [Full Text] [Related]

  • 17. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J, Wang C, Li S, Li S, Wang W, Li J, Chi Y, Yang H, Kong X, Zhou Y, Dong C, Wang F, Xu G, Yang J, Gustafsson JÅ, Guan Y.
    Hepatology; 2013 Aug 22; 58(2):617-28. PubMed ID: 23348573
    [Abstract] [Full Text] [Related]

  • 18. The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance.
    Gao M, Liu D.
    AAPS J; 2013 Jan 22; 15(1):258-66. PubMed ID: 23180161
    [Abstract] [Full Text] [Related]

  • 19. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS, Murphy AJ, Abramowicz S, Ntonga V, Welch CL, Tall AR, Westerterp M.
    Arterioscler Thromb Vasc Biol; 2014 Feb 22; 34(2):279-84. PubMed ID: 24311381
    [Abstract] [Full Text] [Related]

  • 20. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K, Kamada T.
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb 22; 158(2):201-6. PubMed ID: 21056113
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.